 Phoenix, Arizona--Newsfile Corp. - February 1, 2021 - The Stock Day Podcast welcomed Alimera Sciences, Inc. NASDAQ: ALIM the Company, a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. President and CEO of the Company, Rick Eiswirth, joined Stock Day host Everett Jolly. Jolly began the interview by asking about the Companys background and current projects. We are an ophthalmology company, so were focused on finding ways to treat diseases... 